Molecular Cancer Genomics
Nexomics offers state-of-the-art molecular services on multiple high-throughput test platforms that can interrogate RNA, DNA, ctDNA and protein from a large number of samples simultaneously.
We provide clinicians with a personalised and user friendly reporting that outlines the genomic findings and patient treatment options.
Nexomics regularly works in partnership with collaborators to design clinical grade tumour specific assays for tumour profiling to support patient care, basic research and clinical research with an emphasis on ancillary biomarker studies in small and large scale clinical trials.
The laboratory can also offer agile assay and pipeline development, sequence analysis provision through our integrated PathOS web based genomics reporting system. Variant classification and curation services are available through our highly skilled curator team.
Familial cancers
Breast, ovarian, endometrial, prostate, GI, colorectal and pancreatic
Solid cancers
Lung, melanoma, GI, colorectal, and CUP
Haematological malignancies
Myeloid, lymphoid, and MRD monitoring
Clinical trials service provision for pharma/CROs